Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CNY 267.65 million compared to CNY 250.53 million a year ago. Net income was CNY 15.63 million compared to CNY 15.54 million a year ago. Basic earnings per share from continuing operations was CNY 0.0093 compared to CNY 0.0093 a year ago.
For the nine months, sales was CNY 823.18 million compared to CNY 689.4 million a year ago. Net income was CNY 45.51 million compared to CNY 35.89 million a year ago. Basic earnings per share from continuing operations was CNY 0.0271 compared to CNY 0.0214 a year ago.